Specifications tableSubjectComputational and *in silico* ChemistrySpecific subject areaDocking studiesType of dataTable\
FigureHow data were acquiredChemDraw Ultra 8.0 and Molecular docking (AutoDockTools-1. 5. 4)Data formatRaw\
AnalyzedParameters for data collectionThe docking of the tautomeric and enantiomeric forms of ATTAF-1 and ATTAF-2 was targeted at a 6 Å radius area that encompassed the heme of lanosterol-14α-demethylase (PDBs: 5JLC, 5V5Z, 3LD6) using bond type and distance and interactions of proteins with the ligands.Description of data collectionThe Proteins were collected from Protein Data Bank ([www.rcsb.org](http://www.rcsb.org){#interref0004}).\
Ligands 3D structures were obtained by using ChemDraw Ultra 8.0 and energy minimized using PM3 force field. The docking was done using AutoDockTools-1. 5. 4. Searching algorithm in docking study was lamarckian genetic algorithm.Data source locationInstitution: Mazandaran University of Medical Sciences\
City/Town/Region: Sari, Farahabad\
Country: IranData accessibilityData is with this article.Related research articleH. Irannejad, S. Emami, H. Mirzaei, S. M. Hashemi, *In silico* prediction of ATTAF-1 and ATTAF-2 selectivity towards human/fungal lanosterol 14α-demethylase using molecular dynamic simulation and docking approaches, [https://doi.org/10.1016/j.imu.2020.100366](http://doi.org/10.1016/j.imu.2020.100366){#interref0001a}.

Value of the data {#sec0001a}
=================

•The lanosterol 14α-demethylase has been identified as a molecular target for the treatment of fungal diseases.•The modeling data was produced to rationalize the structural necessities for lanosterol 14α-demethylase inhibition.•The binding conformations of the ATTAF-1 and ATTAF-2, their interactions with human and fungal lanosterol 14α-demethylase and coordination bond distance may inform further studies focused on the development of lanosterol 14α-demethylase inhibitors.•Novel synthetic analogues with improved bioactivity and minimized side effects can be expanded against this target by using this *in silico* docking data and research time can be minimized significantly.•This dataset can be useful to model other potent antifungal agents in future and researchers in pharmaceutical chemistry can gain from the data.

1. Data description {#sec0001}
===================

Lanosterol-14α-demethylase (CYP51) is found in mycobacteria, fungi, plants, animals and humans. This enzyme is required for biosynthesis of sterol in eukaryotes and is the major target for azole antifungal agents \[[@bib0001],[@bib0002]\]. In mammals, lanosterol-14α-demethylase is the enzyme that catalyzes lanosterol to cholesterol conversion, which is necessary to maintain a variety of metabolic functions [@bib0003]. An ideal antifungal agent should have minimal effect on human CYP51 enzymes while keeping potent inhibition of fungal enzyme to reduce the side effects [@bib0004]. Lanosterol-14α-demethylase consists of an iron protoporphyrin unit in its active site. At the molecular level, N-4 in the 1,2,4-triazole ring selectively coordinates to the lanosterol-14α-demethylase heme iron and cause the prevention of the fungal ergosterol biosynthesis pathway [@bib0005]. In order support a medicinal chemistry campaign to develop potent azole antifungal agents with high CYP51 affinity, we have previously synthesized and reported a series of novel fluconazole analogues, with the most promising ones introduced as ATTAF-1 and ATTAF-2 [@bib0006] and provided the computational-based docking and MD simulation outputs for all tautomeric and enantiomeric forms of ATTAF-1 and ATTAF-2 plus 8 antifungal standard drugs were docked into the human and fungal lanosterol-14α-demethylase [@bib0009]. Here, our studies provide important protein-ligand interaction information for the further development of lanosterol-14α-demethylase inhibitors. In this article [Table 1](#tbl0001){ref-type="table"} provides the details about the targets and their description. [Table 2](#tbl0002){ref-type="table"} gives the coordinates of the cubic box used to dock ATTAF-1 and ATTAF-2 to the fungal and human CYP51. [Table 3](#tbl0003){ref-type="table"} gives the length of the Fe-N coordination bond. [Table 4](#tbl0004){ref-type="table"} provides tautomers and enantiomers of ATTAF-1 and ATTAF-2 interactions with fungal and human CYP51. To point to the N-4 coordination with heme iron, 3D interactions of all tautomeric and enantiomeric forms of ATTAF-1 and ATTAF-2 with the target enzymes are shown in the [Fig. 1](#fig0001){ref-type="fig"}, [Fig. 2](#fig0002){ref-type="fig"}, [Fig. 3](#fig0003){ref-type="fig"}. 2D interactions of all tautomeric and enantiomeric forms of ATTAF-1, ATTAF-2 and 8 standard triazole antifungal drugs with the target enzymes are shown in the supplemental file .Table 1List of targets.Table 1EntryPDB IDResolution (Å)DescriptionRMSD (Å)1[5V5Z](pdb:5V5Z){#interref0001}2.9Structure of CYP51 from the pathogen *Candida albicans*[@bib0007]1.712[5JLC](pdb:5JLC){#interref0002}2.4Structure of CYP51 from the pathogen *Candida glabrata*[@bib0007]1.583[3LD6](pdb:3LD6){#interref0003}2.8Crystal structure of human lanosterol 14alpha-demethylase (CYP51) in complex with ketoconazole [@bib0008]1.04Table 2Coordinates of the cubic box used to dock ATTAF-1 and ATTAF-2 to the fungal and human CYP51.Table 2EntrySideCoordinateCACYP51CGCYP51hCYP511X−42.490−40.05642.2872Y−13.52374.8504.9693Z26.334−23.5641.219Table 3Length of the Fe-N coordination bond.Table 3EntryCompoundCoordination Bond Distance (Å)CACYP51CGCYP51hCYP511(*R*)-N1-ATTAF-12.522.932.172(*R*)-N2-ATTAF-12.212.63**6.36**3(*R*)-N4-ATTAF-12.912.251.924(*S*)-N1-ATTAF-12.562.442.835(*S*)-N2-ATTAF-12.292.892.926(*S*)-N4-ATTAF-12.532.802.707(*R*)-N1-ATTAF-22.322.832.678(*R*)-N2-ATTAF-22.122.852.199(*R*)-N4-ATTAF-22.202.262.0310(*S*)-N1-ATTAF-22.332.80**4.19**11(*S*)-N2-ATTAF-22.452.862.0412(*S*)-N4-ATTAF-22.742.743.12Table 4Tautomers and enantiomers of ATTAF-1 and ATTAF-2 interactions with fungal and human CYP51.Table 4EntryTargetLigandInteractionType of interactionBond distance (Å)1.**5V5Z**(*R*)-N1-ATTAF-1Tyr132\
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4.21Fig. 1Ligand interaction map of the predicted binding mode of tautomers and enantiomers of ATTAF-1 and ATTAF-2 in the active site *Candida albicans* CYP51.Fig 1Fig. 2Ligand interaction map of the predicted binding mode of tautomers and enantiomers of ATTAF-1 and ATTAF-2 in the active site *Candida glabrata* CYP51.Fig 2Fig. 3Ligand interaction map of the predicted binding mode of tautomers and enantiomers of ATTAF-1 and ATTAF-2 in the active site human CYP51.Fig 3

2. Experimental design, materials and methods {#sec0002}
=============================================

2.1. Protein selection and preparation {#sec0003}
--------------------------------------

The crystal structures of the selected proteins were retrieved from protein data bank. (PDB database, [www.rcsb.org](http://www.rcsb.org){#interref0005}). Protein preparation was done by preprocessing the structures by removing water molecules, ions and cocrystallized ligands, polar hydrogens addition and assigning Gasteiger-Marsili partial charges, adjusting bonds and formal charges for metals, and removing unwanted chains. In order to rmsd validation, the co-crystallized ligand was re-docked. The target input files were converted to PDBQT format for AutoDock by using the AutoDockTools-1. 5. 4.

2.2. Ligand preparation and molecular docking {#sec0004}
---------------------------------------------

Ligands 3D structures were sketched by using ChemDraw Ultra 8.0 and energy minimized using PM3 force field. For all ligands, the nonpolar hydrogen atoms were merged and the Gasteiger charges were assigned. Then set number of torsion with detect root and choose torsion in Autodock program. Later, ligand input files were also saved as PDBQT format utilizing the AutoDock Tools. The minimized structures were docked on the prepared protein.

Discovery Studio Client 2016 and Molegro Molecular Viewer were used for further analysis.
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